(Q39037892)

8 September 2017

title

A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers (English)

1 reference

8 September 2017

0 references

0 references

15

1 reference

8 September 2017

Ralf Reilmann

12

0 references

Hans Johnson

object named as

Hans J Johnson

13

0 references

Blair R Leavitt

17

object named as

Blair R Leavitt

1 reference

8 September 2017

14

Michael R Hayden

1 reference

8 September 2017

Aaron Sturrock

1

1 reference

8 September 2017

Corree Laule

2

1 reference

8 September 2017

Katy Wyper

3

1 reference

8 September 2017

Ruth A Milner

4

1 reference

8 September 2017

Joji Decolongon

5

1 reference

8 September 2017

Rachelle Dar Santos

6

1 reference

8 September 2017

Allison J Coleman

7

1 reference

8 September 2017

Kimberley Carter

8

1 reference

8 September 2017

Susan Creighton

9

1 reference

8 September 2017

Natalie Bechtel

10

1 reference

8 September 2017

Stefan Bohlen

11

1 reference

8 September 2017

Alex L Mackay

16

1 reference

8 September 2017

language of work or name

English

0 references

publication date

18 February 2015

1 reference

8 September 2017

1 reference

8 September 2017

volume

30

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

393-401

1 reference

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

8 September 2017

cites work

1 reference

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data

21 January 2018

1 reference

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis

21 January 2018

1 reference

Detection of Huntington's disease decades before diagnosis: the Predict-HD study

21 January 2018

1 reference

Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease.

21 January 2018

1 reference

Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases

21 January 2018

1 reference

1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers

21 January 2018

1 reference

Clinical correlation of striatal 1H MRS changes in Huntington's disease

21 January 2018

1 reference

Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease

21 January 2018

1 reference

Decreased frontal choline and neuropsychological performance in preclinical Huntington disease

21 January 2018

1 reference

1H magnetic resonance spectroscopy in preclinical Huntington disease

21 January 2018

1 reference

Evidence of thalamic dysfunction in Huntington disease by proton magnetic resonance spectroscopy

21 January 2018

1 reference

Huntington disease: Clinical care and evaluation

21 January 2018

1 reference

CAG repeat number governs the development rate of pathology in Huntington's disease

21 January 2018

1 reference

Structural MR image processing using the BRAINS2 toolbox.

21 January 2018

1 reference

Riluzole therapy in Huntington's disease (HD).

21 January 2018

1 reference

Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study.

21 January 2018

1 reference

High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.

21 January 2018

1 reference

Creatine supplementation lowers brain glutamate levels in Huntington's disease

21 January 2018

1 reference

Proton MRS in Huntington's disease

21 January 2018

1 reference

Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory

21 January 2018

1 reference

Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease

21 January 2018

1 reference

Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy.

21 January 2018

1 reference

Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia

21 January 2018

1 reference

Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.

21 January 2018

1 reference

Synthesis of N-acetyl-l-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport

21 January 2018

1 reference

Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease

21 January 2018

1 reference

Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease.

21 January 2018

1 reference

Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.

21 January 2018

1 reference

Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy

21 January 2018

1 reference

Neurochemical correlates of caudate atrophy in Huntington's disease

21 January 2018

1 reference

Neuroprotection with glatiramer acetate: evidence from the PreCISe trial

21 January 2018

1 reference

Reversible decreases in N-acetylaspartate after acute brain injury

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.26118

1 reference

8 September 2017

1 reference